MedicalCV inks Premier valve pact
This article was originally published in The Gray Sheet
Executive Summary
Three-year U.S. supply agreement with group purchasing firm Premier covers MedicalCV's Omnicarbon mechanical heart valve, approved by FDA in July 2001. The Minnesota firm currently holds less than 1% of the $400 mil. U.S. mechanical heart valve market - having generated $3.1 mil. in Omnicarbon sales during fiscal 2002. Concurrent with the Premier contract, MedicalCV expects to increase its U.S. direct sales force from three to nine, facilitating Omnicarbon sales and preparing for a third-quarter launch of the Northrup Universal annuloplasty system for mitral and tricuspid valve repair, pending FDA approval...